neostigmine has been researched along with vecuronium bromide in 123 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 43 (34.96) | 18.7374 |
| 1990's | 41 (33.33) | 18.2507 |
| 2000's | 19 (15.45) | 29.6817 |
| 2010's | 13 (10.57) | 24.3611 |
| 2020's | 7 (5.69) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Barvais, L; Baurain, MJ; d'Hollander, AA; Dernovoi, BS | 1 |
| Orlowski, M; Pollard, BJ | 1 |
| Cooper, R; McCarthy, GJ; Mirakhur, RK; Stanley, JC | 1 |
| Barvais, L; Baurain, MJ; d'Hollander, AA; Dernovoi, BS; Melot, C | 1 |
| Bentley, JB; Lahet, BS | 1 |
| Dernovoi, BS | 1 |
| Chang, CL; Ho, ST; Ho, W; Hou, CC; Lin, CY; Yen, MH | 1 |
| Coldwell, J; Kitts, J; Miller, RD; Rodriguez, R; Sheiner, LB; Verotta, D | 1 |
| Hollway, TE; Telford, RJ | 1 |
| Caldwell, JE; Lynam, DP; Magorian, TT; Miller, RD | 1 |
| Barvais, L; Baurain, M; d'Hollander, A; Hennart, D | 1 |
| Harper, NJ; Johnson, RA | 1 |
| Bevan, DR; Donati, F; Smith, CE | 1 |
| Schindler, MB | 1 |
| Kim, JM; Mangold, J | 1 |
| d'Hollander, A; Debaene, B; Meistelman, C | 1 |
| Brusset, A; Chauvin, M; Duvaldestin, P; Lebrault, C | 1 |
| Meistelman, C; Thomas-Renard, B; Truffa-Bachi, J | 1 |
| Bell, CF; Hunter, JM; Jones, RS; Utting, JE | 1 |
| Jones, RS | 1 |
| Braidwood, JM; Caldwell, JE; Simpson, DS | 1 |
| Engbaek, J; Ording, H; Ostergaard, D; Viby-Mogensen, J | 1 |
| Bell, CF; Florence, AM; Hunter, JM; Jones, RS; Utting, JE | 1 |
| Ohta, Y | 1 |
| Cronnelly, R; McChristian, JW; Miller, RD; Rupp, SM; Taboada, JA | 1 |
| Savarese, JJ | 1 |
| Payne, JP | 1 |
| Baird, WL; Caldwell, JE; Robertson, EN | 2 |
| Kopman, AF | 1 |
| Gibson, FM; Lavery, GG; Mirakhur, RK | 1 |
| Agoston, S; Barvais, L; Baurain, M; d'Hollander, A; Dernovoi, B; Lefebvre, R | 1 |
| Astley, BA; Katz, RL; Payne, JP | 1 |
| Baar, H; Lazarus, G; Sold, M | 1 |
| Cody, MW; Dormon, FM | 1 |
| Baker, T; Stanec, A | 1 |
| Hunter, JM; Jones, JE; Utting, JE | 1 |
| Albee, DT; Henry, JD; McAnallen, K; Yungbluth, J | 1 |
| d'Hollander, A; Debaene, B; Donati, F; Meistelman, C; Saint-Maurice, C | 1 |
| Hunter, JM; Jones, JE; Parker, CJ | 1 |
| Booij, LH; Crul, JF; Krieg, N; Mazur, L | 1 |
| Cronnelly, R; Fahey, MR; Gencarelli, P; Miller, RD; Morris, RB; Sohn, YJ | 1 |
| Gencarelli, PJ; Miller, RD | 1 |
| Baird, WL; Bowman, WC; Kerr, WJ | 1 |
| Booij, LH; Crul, JF; van der Pol, F | 1 |
| Baird, WL; Kerr, WJ | 1 |
| Bevan, DR; Gyasi, H; Melloni, C; Williams, A | 1 |
| Bali, IM; Clarke, RS; Dundee, JW; Ferres, CJ; Mirakhur, RK | 1 |
| Engbaek, J; Ording, H; Viby-Mogensen, J | 1 |
| Hunter, JM; Jones, RS; Utting, JE | 1 |
| Engbaek, J; Ording, H; Pedersen, T; Viby-Mogensen, J | 1 |
| Cronnelly, R; Fahey, MR; Fisher, DM; Miller, RD; Rupp, SM; Sohn, YJ | 1 |
| Brown, R; Fisher, DM; Lau, M; Sharma, ML; Szenohradszky, J | 1 |
| Caldwell, JE | 1 |
| Fujita, T; Morita, T; Saito, S; Sato, H; Sugaya, T; Tsukagoshi, H | 1 |
| Baer, GA; Puura, AI; Rorarius, MG | 1 |
| Norman, J | 1 |
| Boeke, AJ; de Lange, JJ; Langemeijer, JJ; van Druenen, B | 1 |
| Debaene, B; Donati, F; Frossard, J; Meistelman, C; Plaud, B; Salib, Y | 1 |
| Wilhite, AO | 1 |
| Bourgain, JL; Debaene, B; Donati, F; Meistelman, C | 1 |
| Hennis, PJ; Proost, JH; van den Broek, L; Verbaan, BW; Wierda, JM | 1 |
| Mirakhur, RK | 1 |
| Kirkegaard-Nielsen, H; May, O; Severinsen, IK; Toft, P | 1 |
| Chung, RA; Fairley, CJ; Fawcett, WJ; Hollway, TE | 1 |
| De Chaubry, V; Dhonneur, G; Duvaldestin, P; Rebaine, C; Ruggier, R; Slavov, V | 1 |
| Baurain, MJ; d'Hollander, AA; Dernovoi, BS; Hoton, F | 1 |
| Bülow, K; Helbo-Hansen, HS; Kirkegaard-Nielsen, H; Lindholm, P; Severinsen, IK | 1 |
| Baurain, MJ; Cantraine, FR; D'Hollander, AA; Dernovoi, BS; Hennart, DA | 1 |
| Antognini, JF; Fleming, NW; Macres, S; Vengco, J | 1 |
| Baurain, MJ; Cantraine, FR; D'Hollander, AA; Hoton, F | 1 |
| Gyermek, L | 1 |
| Fukushima, K; Izawa, H; Takeda, J | 1 |
| Goto, F; Kurosaki, D; Morita, T; Sato, H; Shimada, H; Tsukagoshi, H | 1 |
| Fontenot, JP; Stevens, JB; Walker, SC | 1 |
| Aubineau, JV; D'Honneur, G; Drummond, GB; Duvaldestin, P; Harf, A; Lofaso, F; Rimaniol, JM | 1 |
| Anderson, KA; Booij, LH; Hill, DR; Marshall, RJ; Muir, AW; Pow, E; Sleigh, T | 1 |
| Fuchs-Buder, T; Lysakowski, K; Tassonyi, E; Ziegenfuss, T | 1 |
| Bevan, DR; Donati, F; Lichtor, JL; Purdy, R | 1 |
| Bevan, DR; Bevan, JC; Collins, L; de Scheepers, LD; Fowler, C; Kahwaji, R; Rosen, HD; Smith, MF; Stephenson, CA | 1 |
| Ahuja, S; Hussain, S; Jain, AK | 1 |
| Carroll, MT; Lowry, DW; McCourt, KC; Mirakhur, RK; Sparr, HJ | 1 |
| Danjoux, G; Hing, JP; Hunter, JM; Mills, KG; Pollard, BJ; Scott, JM; Wright, PM | 1 |
| Borsa, S; Pignataro, A; Pozzato, M; Quarello, F; Rollino, C; Vallero, A; Visetti, E | 1 |
| Breslin, D; Hayes, A; Mirakhur, RK; Reid, J | 1 |
| Bartkowski, R; Bikhazi, G; Donati, F; Goldberg, ME; Kenaan, CA; Larijani, GE; Plaud, B | 1 |
| Bartkowski, RR; Witkowski, TA | 1 |
| Coppens, S; Geerts, E; van Iersel, M; Vanacker, BF | 1 |
| Caldwell, JE; Clough, D; Heier, T; Sessler, DI; Sharma, ML; Wright, PM | 1 |
| Akatu, M; Hattori, H; Murakawa, M; Nakajima, H; Saitoh, Y; Sanbe, N | 1 |
| Bourke, DL; Hall, BA; Keegan, MT; Ramirez, JG; Sprung, J | 1 |
| Alkhazrajy, W; Khorasanee, AD; Russell, WJ | 1 |
| Igari, T; Kido, K; Mizuta, F; Mizuta, K; Takahashi, M; Yasuda, M | 1 |
| Masaki, G; Ogawa, S; Suzuki, T | 1 |
| Chamberlin, NL; Eikermann, M; Fassbender, P; Gautam, S; Jordan, AS; Kubo, S; Malhotra, A; Takahashi, M; White, DP | 1 |
| Murouchi, T; Ohsone, J; Yamakage, M | 1 |
| Katz, RL; Lee, C | 1 |
| Fukano, N; Kitajima, O; Miyake, E; Ogawa, S; Saeki, S; Suzuki, T | 1 |
| Alvarez-Gómez, JA; Khuenl-Brady, KS; Lora-Tamayo, JI; Rietbergen, H; Vanacker, BF; Wattwil, M | 1 |
| Abrishami, A; Chung, F; Ho, J; Wong, J; Yin, L | 1 |
| Debaene, B; Meistelman, C | 1 |
| Plaud, B | 1 |
| Baso, AC; Oliveira, AC; Serra, CS | 1 |
| Aoki, K; Hirama, T; Isosu, T; Murakawa, M; Okazaki, M; Saitoh, Y | 1 |
| Beck, G; Geldner, G; Hübler, M; Laurila, P; Mizikov, V; Nicolayenko, E; Niskanen, M; Rietbergen, H | 1 |
| Baldivieso, JM; Himelfarb, MA; Litterio, NJ; Lorenzutti, AM; Martin-Flores, M | 1 |
| Ayata, C; Blobner, M; Diaz-Gil, D; Eikermann, M; Eikermann-Haerter, K; Foerster, U; Ganapati, S; Haerter, F; Isaacs, L; Moreno Duarte, I; Simons, JC; Zhang, B | 1 |
| Aguirre, GE; Bonetto, CC; Litterio, NJ; Lorenzutti, AM; Martin-Flores, M; Rossetti, VL; Zarazaga, MP | 1 |
| Carron, M; Ori, C; Tellaroli, P; Zarantonello, F | 1 |
| Carron, M; Lazzarotto, N; Ori, C; Tellaroli, P; Zarantonello, F | 1 |
| Assaid, CA; Blobner, M; Herring, WJ; Khuenl-Brady, KS; Lemmens, HJ; Lupinacci, RJ; Woo, T | 1 |
| Beutler, SS; Gimlich, R; Palsen, S; Urman, RD; Wu, A; Yang, HK | 1 |
| Badeaux, J; Martin, J; Schiavo, JH; Yellott, E | 1 |
| Brull, SJ; Carlos, RV; de Boer, HD | 1 |
| Raymond, BL; Richardson, MG | 1 |
| He, H; He, J; Lai, Z; Li, X; Sun, M; Xu, B | 1 |
| Blobner, M; Broussard, DM; Herring, WJ; Lin, L; Lombard, JF; Lutkiewicz, J; Mukai, Y; Wang, A; Watkins, M | 1 |
| Bash, LD; Black, W; Turzhitsky, V; Urman, RD | 1 |
| DeAngelis, M; Hammer, GB; Herring, WJ; Saldien, V; Speek, M; Voss, T; Wang, A; Wrishko, R | 1 |
| Schenning, KJ; Togioka, BM | 1 |
| Carrillo-Martin, I; Garzon-Siatoya, WT; Gonzalez-Estrada, A; Hernandez-Torres, V; Morgenstern-Kaplan, D; Renew, JR; Volcheck, GW | 1 |
12 review(s) available for neostigmine and vecuronium bromide
| Article | Year |
|---|---|
Clinical relaxation: current controversy.
Topics: Androstane-3,17-diol; Anesthesia; Atracurium; Cholinesterase Inhibitors; Humans; Intubation, Intratracheal; Isoquinolines; Mivacurium; Muscle Relaxants, Central; Neostigmine; Neuromuscular Blocking Agents; Neuromuscular Nondepolarizing Agents; Pancuronium; Pipecuronium; Piperazines; Vecuronium Bromide | 1986 |
Clinical pharmacology of vecuronium and atracurium.
Topics: Acid-Base Equilibrium; Adolescent; Adult; Age Factors; Aged; Anesthesia; Anesthesia, Obstetrical; Atracurium; Cardiopulmonary Bypass; Cardiovascular System; Cesarean Section; Chemical Phenomena; Chemistry; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Humans; Infant; Infant, Newborn; Isoquinolines; Kinetics; Liver Diseases; Middle Aged; Neostigmine; Neuromuscular Blocking Agents; Pancuronium; Pregnancy; Succinylcholine; Time Factors; Vecuronium Bromide | 1984 |
Spontaneous recovery or evoked reversal of neuromuscular block.
Topics: Anesthesia Recovery Period; Atracurium; Cholinesterase Inhibitors; Edrophonium; Humans; Isoquinolines; Mivacurium; Neostigmine; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Pyridostigmine Bromide; Time Factors; Vecuronium Bromide | 1995 |
[Reversal of neuromuscular blockade and complications of remaining blocking effect].
Topics: Androstanols; Anesthesia Recovery Period; Cholinesterase Inhibitors; Clinical Trials, Phase III as Topic; gamma-Cyclodextrins; Humans; Neostigmine; Neuromuscular Blocking Agents; Neuromuscular Diseases; Pancuronium; Rocuronium; Sugammadex; Vecuronium Bromide | 2008 |
Clinical implications of new neuromuscular concepts and agents: so long, neostigmine! So long, sux!
Topics: Androstanols; Anesthesia Recovery Period; Chemistry, Pharmaceutical; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Design; Drug Monitoring; Drug Utilization; Edrophonium; Forecasting; gamma-Cyclodextrins; Humans; Monitoring, Intraoperative; Neostigmine; Neuromuscular Blockade; Neuromuscular Nondepolarizing Agents; Patient Selection; Pyridostigmine Bromide; Rocuronium; Safety; Succinylcholine; Sugammadex; Vecuronium Bromide | 2009 |
Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
Topics: Adult; Androstanols; Cholinesterase Inhibitors; gamma-Cyclodextrins; Humans; Neostigmine; Neuromuscular Blockade; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Pancuronium; Randomized Controlled Trials as Topic; Rocuronium; Sugammadex; Vecuronium Bromide | 2009 |
[Indications and clinical use of sugammadex].
Topics: Algorithms; Androstanols; Anesthesia Recovery Period; Clinical Trials, Phase III as Topic; Contraindications; Electrodiagnosis; gamma-Cyclodextrins; Humans; Kidney Failure, Chronic; Muscle Relaxation; Neostigmine; Neuromuscular Blockade; Neuromuscular Nondepolarizing Agents; Postoperative Complications; Randomized Controlled Trials as Topic; Respiratory Paralysis; Rocuronium; Sugammadex; Vecuronium Bromide | 2009 |
[Sugammadex: something new to improve patient safety or simply a gadget?].
Topics: Androstanols; Anesthesia Recovery Period; Atracurium; Cost-Benefit Analysis; Drug Approval; Electrodiagnosis; France; gamma-Cyclodextrins; Humans; Monitoring, Physiologic; Muscle Relaxation; Neostigmine; Neuromuscular Blockade; Neuromuscular Nondepolarizing Agents; Postoperative Complications; Respiratory Paralysis; Rocuronium; Sugammadex; United States; Vecuronium Bromide | 2009 |
Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials.
Topics: Androstanols; Anesthesia Recovery Period; Cholinesterase Inhibitors; gamma-Cyclodextrins; Humans; Neostigmine; Neuromuscular Blockade; Neuromuscular Nondepolarizing Agents; Randomized Controlled Trials as Topic; Rocuronium; Sugammadex; Treatment Outcome; Vecuronium Bromide | 2016 |
Role of sugammadex in accelerating postoperative discharge: A meta-analysis.
Topics: Androstanols; Anesthesia, General; gamma-Cyclodextrins; Humans; Neostigmine; Neuromuscular Blockade; Neuromuscular Nondepolarizing Agents; Randomized Controlled Trials as Topic; Rocuronium; Sugammadex; Vecuronium Bromide | 2017 |
Is lower-dose sugammadex a cost-saving strategy for reversal of deep neuromuscular block? Facts and fiction.
Topics: Cost Savings; Dose-Response Relationship, Drug; Humans; Neostigmine; Neuromuscular Blockade; Neuromuscular Monitoring; Neuromuscular Nondepolarizing Agents; Rocuronium; Sugammadex; Vecuronium Bromide | 2018 |
Sugammadex Administration in Pregnant Women and in Women of Reproductive Potential: A Narrative Review.
Topics: Adult; Anesthesia Recovery Period; Anesthesia, General; Anesthesia, Obstetrical; Cesarean Section; Cholinesterase Inhibitors; Female; Humans; Intubation; Lactation; Neostigmine; Neuromuscular Blockade; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Placenta; Postpartum Period; Pregnancy; Pregnancy Complications; Rocuronium; Sugammadex; Vecuronium Bromide | 2020 |
44 trial(s) available for neostigmine and vecuronium bromide
| Article | Year |
|---|---|
The influence of atropine dose on recovery from vecuronium-induced neuromuscular blockade.
Topics: Adult; Anesthesia Recovery Period; Atropine; Humans; Neostigmine; Neuromuscular Junction; Surgical Procedures, Operative; Time Factors; Vecuronium Bromide | 1992 |
Effect of doxapram on neostigmine evoked antagonism of vecuronium neuromuscular block.
Topics: Adult; Anesthesia, General; Depression, Chemical; Double-Blind Method; Doxapram; Drug Interactions; Female; Glycopyrrolate; Humans; Muscle Contraction; Neostigmine; Time Factors; Vecuronium Bromide | 1992 |
Dose-response relationships for neostigmine antagonism of vecuronium-induced neuromuscular block in adults and the elderly.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Dose-Response Relationship, Drug; Humans; Middle Aged; Neostigmine; Nerve Block; Neuromuscular Junction; Time Factors; Vecuronium Bromide | 1992 |
Effects of residual concentrations of isoflurane on the reversal of vecuronium-induced neuromuscular blockade.
Topics: Adult; Anesthesia, Inhalation; Humans; Isoflurane; Middle Aged; Neostigmine; Neuromuscular Junction; Surgical Procedures, Operative; Vecuronium Bromide | 1991 |
Antagonism of vecuronium paralysis: comparison between edrophonium and neostigmine.
Topics: Adolescent; Adult; Child; Edrophonium; Humans; Middle Aged; Neostigmine; Neuromuscular Junction; Vecuronium Bromide | 1991 |
Can early administration of neostigmine, in single or repeated doses, alter the course of neuromuscular recovery from a vecuronium-induced neuromuscular blockade?
Topics: Adult; Female; Humans; Male; Middle Aged; Neostigmine; Neuromuscular Junction; Randomized Controlled Trials as Topic; Time Factors; Vecuronium Bromide | 1990 |
Antagonism of moderate degrees of vecuronium-induced neuromuscular block by small doses of neostigmine.
Topics: Adult; Anesthesia Recovery Period; Female; Humans; Neostigmine; Neuromuscular Junction; Vecuronium Bromide | 1989 |
Dose-response relationships for edrophonium and neostigmine as antagonists of atracurium and vecuronium neuromuscular blockade.
Topics: Atracurium; Dose-Response Relationship, Drug; Edrophonium; Electric Stimulation; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Neostigmine; Neuromuscular Junction; Random Allocation; Time Factors; Ulnar Nerve; Vecuronium Bromide | 1989 |
Antagonism of profound neuromuscular blockade induced by vecuronium or atracurium. Comparison of neostigmine with edrophonium.
Topics: Adult; Atracurium; Edrophonium; Humans; Middle Aged; Muscle Contraction; Neostigmine; Neuromuscular Blocking Agents; Time Factors; Vecuronium Bromide | 1986 |
Antagonism of vecuronium-induced neuromuscular blockade with edrophonium or neostigmine.
Topics: Adult; Edrophonium; Humans; Muscle Contraction; Neostigmine; Time Factors; Vecuronium Bromide | 1987 |
Antagonism of vecuronium and atracurium: comparison of neostigmine and edrophonium administered at 5% twitch height recovery.
Topics: Adult; Atracurium; Edrophonium; Humans; Muscle Contraction; Neostigmine; Time Factors; Vecuronium Bromide | 1987 |
Use of neostigmine in the antagonism of residual neuromuscular blockade produced by vecuronium.
Topics: Adult; Female; Humans; Male; Neostigmine; Neuromuscular Junction; Synaptic Transmission; Time Factors; Vecuronium Bromide | 1987 |
Recovery characteristics following antagonism of vecuronium with edrophonium, neostigmine or pyridostigmine.
Topics: Adult; Aged; Arrhythmias, Cardiac; Blood Pressure; Cholinesterase Inhibitors; Clinical Trials as Topic; Edrophonium; Female; Humans; Middle Aged; Neostigmine; Neuromuscular Junction; Pyridostigmine Bromide; Random Allocation; Vecuronium Bromide | 1988 |
Antagonism of org NC 45 (vecuronium) and pancuronium neuromuscular blockade by neostigmine.
Topics: Adult; Dose-Response Relationship, Drug; Humans; Middle Aged; Neostigmine; Neuromuscular Blocking Agents; Pancuronium; Time Factors; Vecuronium Bromide | 1982 |
Clinical studies on Org NC 45: comparison with pancuronium.
Topics: Blood Pressure; Heart Rate; Humans; Intraoperative Period; Intubation, Intratracheal; Muscle Contraction; Neostigmine; Neuromuscular Blocking Agents; Pancuronium; Time Factors; Vecuronium Bromide | 1982 |
Neuromuscular blocking effects of vecuronium and pancuronium during halothane anaesthesia.
Topics: Adult; Anesthesia, Inhalation; Female; Halothane; Humans; Muscle Contraction; Neostigmine; Neuromuscular Blocking Agents; Pancuronium; Time Factors; Vecuronium Bromide | 1983 |
Dose-response relationships and neuromuscular blocking effects of vecuronium pancuronium during ketamine anaesthesia.
Topics: Adult; Anesthesia, Intravenous; Dose-Response Relationship, Drug; Female; Humans; Ketamine; Muscle Contraction; Neostigmine; Neuromuscular Blocking Agents; Pancuronium; Therapeutic Equivalency; Time Factors; Vecuronium Bromide | 1984 |
Edrophonium is better than neostigmine to antagonize residual vecuronium induced neuromuscular block.
Topics: Adult; Anesthesia Recovery Period; Atropine; Edrophonium; Electromyography; Glycopyrrolate; Humans; Middle Aged; Neostigmine; Vecuronium Bromide | 1994 |
Effect of antagonizing residual neuromuscular block by neostigmine and atropine on postoperative vomiting.
Topics: Adolescent; Adult; Aged; Ambulatory Surgical Procedures; Anesthesia, General; Atropine; Female; Humans; Incidence; Male; Middle Aged; Nausea; Neostigmine; Postoperative Complications; Vecuronium Bromide; Vomiting | 1994 |
Time course of action and endotracheal intubating conditions of Org 9487, a new short-acting steroidal muscle relaxant; a comparison with succinylcholine.
Topics: Adult; Computer Simulation; Female; Humans; Intubation, Intratracheal; Male; Neostigmine; Neuromuscular Blocking Agents; Random Allocation; Reaction Time; Succinylcholine; Synaptic Transmission; Time Factors; Vecuronium Bromide | 1993 |
Optimum time for neostigmine administration to antagonize vecuronium-induced neuromuscular blockade.
Topics: Adult; Anesthesia Recovery Period; Anesthetics, Intravenous; Cholinesterase Inhibitors; Droperidol; Electric Stimulation; Fentanyl; Humans; Middle Aged; Muscle Contraction; Muscle, Skeletal; Neostigmine; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Regression Analysis; Thiopental; Time Factors; Ulnar Nerve; Vecuronium Bromide | 1995 |
Neostigmine reversal of vecuronium neuromuscular block and the influence of renal failure.
Topics: Adult; Aged; Anesthesia, General; Cholinesterase Inhibitors; Drug Interactions; Humans; Kidney; Middle Aged; Neostigmine; Neuromuscular Nondepolarizing Agents; Renal Insufficiency; Vecuronium Bromide | 1996 |
Influence and relative sensitivities of 50-Hz and 100-Hz tetanic stimuli on subsequent tetanic fade ratios in patients receiving vecuronium.
Topics: Adolescent; Adult; Atropine; Cholinesterase Inhibitors; Electric Stimulation; Evaluation Studies as Topic; Humans; Hypoxia; Isometric Contraction; Middle Aged; Neostigmine; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Sensitivity and Specificity; Synaptic Transmission; Vecuronium Bromide | 1996 |
Time to peak effect of neostigmine at antagonism of atracurium- or vecuronium-induced neuromuscular block.
Topics: Adult; Anesthesia; Atracurium; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Electric Stimulation; Female; Genitalia, Female; Humans; Middle Aged; Muscle, Skeletal; Neostigmine; Nerve Block; Neuromuscular Nondepolarizing Agents; Prospective Studies; Time Factors; Vecuronium Bromide | 1995 |
Conditions to optimise the reversal action of neostigmine upon a vecuronium-induced neuromuscular block.
Topics: Adolescent; Adult; Cholinesterase Inhibitors; Humans; Middle Aged; Neostigmine; Neuromuscular Blockade; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Synaptic Transmission; Vecuronium Bromide | 1996 |
Neuromuscular blocking action of suxamethonium after antagonism of vecuronium by edrophonium, pyridostigmine or neostigmine.
Topics: Adult; Aged; Anesthesia, General; Cholinesterase Inhibitors; Cholinesterases; Drug Interactions; Edrophonium; Female; Humans; Male; Middle Aged; Neostigmine; Neuromuscular Depolarizing Agents; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Pyridostigmine Bromide; Succinylcholine; Vecuronium Bromide | 1996 |
Is recovery of neuromuscular transmission complete after the use of neostigmine to antagonize block produced by rocuronium, vecuronium, atracurium and pancuronium?
Topics: Adult; Androstanols; Anesthesia, General; Atracurium; Cholinesterase Inhibitors; Humans; Middle Aged; Neostigmine; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Pancuronium; Rocuronium; Synaptic Transmission; Vecuronium Bromide | 1996 |
Factors affecting neostigmine reversal of vecuronium block during sevoflurane anaesthesia.
Topics: Adult; Anesthesia, Inhalation; Anesthetics, Inhalation; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Ethers; Female; Humans; Methyl Ethers; Middle Aged; Neostigmine; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Sevoflurane; Vecuronium Bromide | 1997 |
The clinical neuromuscular pharmacology of cisatracurium versus vecuronium during outpatient anesthesia.
Topics: Adolescent; Adult; Ambulatory Surgical Procedures; Anesthesia; Atracurium; Dose-Response Relationship, Drug; Double-Blind Method; Electric Stimulation; Female; Humans; Male; Middle Aged; Muscle Contraction; Muscle Relaxation; Neostigmine; Neuromuscular Blocking Agents; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Synaptic Transmission; Ulnar Nerve; Vecuronium Bromide | 1997 |
Susceptibility to upper airway obstruction during partial neuromuscular block.
Topics: Adult; Airway Obstruction; Airway Resistance; Cholinesterase Inhibitors; Disease Susceptibility; Humans; Infusions, Intravenous; Male; Neostigmine; Neuromuscular Blockade; Neuromuscular Nondepolarizing Agents; Vecuronium Bromide; Work of Breathing | 1998 |
Antagonism of vecuronium-induced neuromuscular block in patients pretreated with magnesium sulphate: dose-effect relationship of neostigmine.
Topics: Adult; Anti-Arrhythmia Agents; Anticonvulsants; Bradycardia; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Electromyography; Female; Humans; Magnesium Sulfate; Male; Middle Aged; Neostigmine; Neuromuscular Blockade; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Prospective Studies; Vecuronium Bromide | 1999 |
Early reversal of rapacuronium with neostigmine.
Topics: Adult; Cholinesterase Inhibitors; Female; Humans; Male; Middle Aged; Neostigmine; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Prospective Studies; Time Factors; Vecuronium Bromide | 1999 |
Early and late reversal of rocuronium and vecuronium with neostigmine in adults and children.
Topics: Adult; Androstanols; Child; Child, Preschool; Cholinesterase Inhibitors; Female; Humans; Male; Neostigmine; Neuromuscular Blockade; Neuromuscular Depolarizing Agents; Neuromuscular Nondepolarizing Agents; Rocuronium; Succinylcholine; Time Factors; Vecuronium Bromide | 1999 |
Spontaneous or neostigmine-induced recovery after maintenance of neuromuscular block with Org 9487 (rapacuronium) or rocuronium following an initial dose of Org 9487.
Topics: Androstanols; Anesthesia, General; Cholinesterase Inhibitors; Drug Administration Schedule; Humans; Neostigmine; Neuromuscular Blockade; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Rocuronium; Vecuronium Bromide | 1999 |
Antagonism of rapacuronium using edrophonium or neostigmine: pharmacodynamics and pharmacokinetics.
Topics: Adolescent; Adult; Aged; Cholinesterase Inhibitors; Drug Administration Schedule; Edrophonium; Female; Humans; Male; Middle Aged; Neostigmine; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Vecuronium Bromide | 1999 |
Comparison of recovery following rapacuronium, with and without neostigmine, and succinylcholine.
Topics: Adolescent; Adult; Anesthesia Recovery Period; Anesthesia, General; Cholinesterase Inhibitors; Female; Humans; Male; Middle Aged; Neostigmine; Neuromuscular Blockade; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Succinylcholine; Vecuronium Bromide | 2000 |
A multicenter evaluation of the time-course of action of two doses of rapacuronium after early and late reversal with neostigmine.
Topics: Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Neostigmine; Neuromuscular Nondepolarizing Agents; Time Factors; Vecuronium Bromide | 2001 |
A comparison of neuromuscular effects, tracheal intubating conditions, and reversibility of rapacuronium versus mivacurium in female patients.
Topics: Cholinesterase Inhibitors; Double-Blind Method; Female; Gynecologic Surgical Procedures; Humans; Intubation, Intratracheal; Isoquinolines; Laparoscopy; Mivacurium; Neostigmine; Neuromuscular Blockade; Neuromuscular Nondepolarizing Agents; Vecuronium Bromide | 2002 |
Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial.
Topics: Adult; Aged; Anesthesia Recovery Period; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Electric Stimulation; Female; gamma-Cyclodextrins; Hemodynamics; Humans; Male; Middle Aged; Neostigmine; Neuromuscular Blockade; Neuromuscular Nondepolarizing Agents; Sugammadex; Vecuronium Bromide | 2010 |
A randomised controlled trial comparing sugammadex and neostigmine at different depths of neuromuscular blockade in patients undergoing laparoscopic surgery.
Topics: Adult; Aged; Androstanols; Anesthesia; Anesthesia Recovery Period; Anesthetics, Intravenous; Cholinesterase Inhibitors; Electric Stimulation; Female; gamma-Cyclodextrins; Heart Rate; Humans; Laparoscopy; Male; Middle Aged; Neostigmine; Neuromuscular Blockade; Neuromuscular Nondepolarizing Agents; Patient Safety; Propofol; Rocuronium; Sample Size; Sugammadex; Vecuronium Bromide; Young Adult | 2012 |
Evaluation of neostigmine antagonism at different levels of vecuronium-induced neuromuscular blockade in isoflurane anesthetized dogs.
Topics: Anesthetics, Inhalation; Animals; Dogs; Female; Isoflurane; Male; Neostigmine; Neuromuscular Blockade; Neuromuscular Nondepolarizing Agents; Vecuronium Bromide | 2014 |
Speed of reversal of vecuronium neuromuscular block with different doses of neostigmine in anesthetized dogs.
Topics: Anesthetics, Inhalation; Animals; Cross-Over Studies; Dogs; Female; Isoflurane; Male; Neostigmine; Neuromuscular Blockade; Neuromuscular Monitoring; Prospective Studies; Vecuronium Bromide | 2017 |
A randomized trial evaluating the safety profile of sugammadex in high surgical risk ASA physical class 3 or 4 participants.
Topics: Aged; Bradycardia; Cholinergic Agents; Double-Blind Method; Female; Glycopyrrolate; Humans; Male; Neostigmine; Neuromuscular Blockade; Neuromuscular Nondepolarizing Agents; Rocuronium; Sugammadex; Tachycardia; Vecuronium Bromide | 2021 |
Sugammadex for reversal of neuromuscular blockade in pediatric patients: Results from a phase IV randomized study.
Topics: Anaphylaxis; Anesthetics; Bradycardia; Child; Humans; Neostigmine; Neuromuscular Blockade; Neuromuscular Nondepolarizing Agents; Rocuronium; Sugammadex; Vecuronium Bromide | 2022 |
67 other study(ies) available for neostigmine and vecuronium bromide
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Antagonism of vecuronium-induced neuromuscular block.
Topics: Anesthesia Recovery Period; Humans; Neostigmine; Neuromuscular Junction; Vecuronium Bromide | 1991 |
Interactions of adenosine and vecuronium in neuromuscular blockade in cats.
Topics: Adenosine; Animals; Blood Pressure; Cats; Drug Synergism; Female; Male; Neostigmine; Neuromuscular Junction; Nitroprusside; Vecuronium Bromide | 1991 |
Reversal of neuromuscular blockade in humans by neostigmine and edrophonium: a mathematical model.
Topics: Adult; Edrophonium; Humans; Mathematics; Middle Aged; Models, Biological; Neostigmine; Vecuronium Bromide | 1991 |
The myasthenic syndrome: anaesthesia in a patient treated with 3.4 diaminopyridine.
Topics: 4-Aminopyridine; Aged; Amifampridine; Anesthesia, General; Glycopyrrolate; Humans; Lambert-Eaton Myasthenic Syndrome; Male; Neostigmine; Potassium Channels; Vecuronium Bromide | 1990 |
Impairment of the antagonism of vecuronium-induced paralysis and intra-operative disopyramide administration.
Topics: Atropine; Disopyramide; Drug Interactions; Humans; Intraoperative Care; Male; Middle Aged; Muscle Contraction; Neostigmine; Time Factors; Vecuronium Bromide | 1989 |
Prolonged neuromuscular blockade following the use of vecuronium for mediastinoscopy.
Topics: Aged; Female; Humans; Mediastinoscopy; Myasthenia Gravis; Neostigmine; Neuromuscular Diseases; Time Factors; Vecuronium Bromide | 1989 |
Sensitivity to both vecuronium and neostigmine in a sero-negative myasthenic patient.
Topics: Adult; Apnea; Female; Humans; Myasthenia Gravis; Neostigmine; Postoperative Complications; Vecuronium Bromide | 1989 |
Recovery from vecuronium neuromuscular blockade following neostigmine administration in infants, children, and adults during halothane anesthesia.
Topics: Adult; Aged; Aging; Anesthesia, Inhalation; Child; Child, Preschool; Halothane; Humans; Infant; Middle Aged; Neostigmine; Neuromuscular Junction; Nitrous Oxide; Time Factors; Vecuronium Bromide | 1989 |
[Comparison of the antagonistic effects of neostigmine and edrophonium on neuromuscular block induced by vecuronium in the diaphragm and thumb adductor].
Topics: Diaphragm; Edrophonium; Humans; Muscles; Neostigmine; Neuromuscular Blocking Agents; Respiratory Muscles; Thumb; Vecuronium Bromide | 1989 |
[Effect of isoflurane concentration on the speed of decurarization of vecuronium after administration of neostigmine].
Topics: Adult; Humans; Isoflurane; Kinetics; Middle Aged; Neostigmine; Vecuronium Bromide | 1989 |
Use of atracurium and vecuronium in patients with oesophageal varices.
Topics: Adult; Aged; Atracurium; Esophageal and Gastric Varices; Female; Humans; Hypertension, Portal; Intubation, Intratracheal; Isoquinolines; Liver Diseases; Liver Function Tests; Male; Middle Aged; Neostigmine; Neuromuscular Blocking Agents; Pancuronium; Sclerosing Solutions; Time Factors; Vecuronium Bromide | 1985 |
Neuromuscular blocking action of vecuronium in the dog and its reversal by neostigmine.
Topics: Analysis of Variance; Anesthesia, General; Animals; Atropine; Blood Pressure; Dogs; Drug Antagonism; Electric Stimulation; Injections, Intravenous; Muscle Contraction; Neostigmine; Neuromuscular Blocking Agents; Neuromuscular Junction; Pancuronium; Vecuronium Bromide | 1985 |
Vecuronium bromide in anaesthesia for laparoscopic sterilization.
Topics: Adult; Anesthesia, General; Female; Humans; Intubation, Intratracheal; Laparoscopy; Neostigmine; Neuromuscular Blocking Agents; Pancuronium; Sterilization, Tubal; Time Factors; Vecuronium Bromide | 1985 |
Edrophonium and neostigmine for reversal of the neuromuscular blocking effect of vecuronium.
Topics: Adult; Edrophonium; Female; Humans; Laparoscopy; Muscle Contraction; Neostigmine; Neuroleptanalgesia; Neuromuscular Blocking Agents; Pancuronium; Vecuronium Bromide | 1985 |
Vecuronium in the myasthenic patient.
Topics: Adolescent; Adult; Aged; Drug Administration Schedule; Drug Evaluation; Female; Humans; Male; Middle Aged; Muscle Contraction; Myasthenia Gravis; Neostigmine; Neuromuscular Blocking Agents; Pancuronium; Time Factors; Vecuronium Bromide | 1985 |
Paradoxical antagonism of neuromuscular block by vecuronium metabolites.
Topics: Animals; Biotransformation; Diaphragm; Drug Interactions; Electric Stimulation; Hexamethonium; Hexamethonium Compounds; Male; Neostigmine; Neuromuscular Blocking Agents; Neuromuscular Junction; Pancuronium; Phrenic Nerve; Rats; Rats, Inbred Strains; Structure-Activity Relationship; Vecuronium Bromide | 1985 |
Neostigmine and edrophonium antagonism of varying intensity neuromuscular blockade induced by atracurium, pancuronium, or vecuronium.
Topics: Anesthesia; Atracurium; Edrophonium; Enflurane; Halothane; Humans; Isoquinolines; Kinetics; Neostigmine; Neuromuscular Junction; Nitrous Oxide; Pancuronium; Time Factors; Vecuronium Bromide | 1986 |
In pursuit of relaxation.
Topics: Anesthesia; Atracurium; Curare; Decamethonium Compounds; History, 20th Century; Humans; Muscle Contraction; Neostigmine; Neuromuscular Blocking Agents; Neuromuscular Junction; Succinylcholine; Synaptic Transmission; Time Factors; Vecuronium Bromide | 1986 |
Recovery times following edrophonium and neostigmine reversal of pancuronium, atracurium, and vecuronium steady-state infusions.
Topics: Atracurium; Edrophonium; Humans; Neostigmine; Neuromuscular Blocking Agents; Pancuronium; Time Factors; Vecuronium Bromide | 1986 |
Neostigmine antagonism of vecuronium paralysis during fentanyl, halothane, isoflurane, and enflurane anesthesia.
Topics: Adult; Anesthesia; Enflurane; Fentanyl; Halothane; Humans; Middle Aged; Neostigmine; Neuromuscular Junction; Vecuronium Bromide | 1987 |
Electrical and mechanical responses after neuromuscular blockade with vecuronium, and subsequent antagonism with neostigmine or edrophonium.
Topics: Adult; Aged; Edrophonium; Electromyography; Humans; Middle Aged; Muscle Contraction; Neostigmine; Neuromuscular Junction; Time Factors; Vecuronium Bromide | 1987 |
[Antagonism of an intubation dose of vecuronium].
Topics: Anesthesia; Edrophonium; Halothane; Humans; Intubation; Muscle Contraction; Muscle Relaxation; Neostigmine; Respiration; Thiopental; Time Factors; Vecuronium Bromide | 1987 |
Recurarisation after vecuronium in a patient with renal failure.
Topics: Acidosis; Adult; Atropine; Female; Humans; Kidney Failure, Chronic; Neostigmine; Neuromuscular Junction; Postoperative Complications; Vecuronium Bromide | 1987 |
Drug actions at mammalian motor nerve endings: the suppression of neostigmine-induced fasciculations by vecuronium and isoflurane.
Topics: Animals; Cats; Fasciculation; Isoflurane; Motor Neurons; Muscles; Neostigmine; Nerve Endings; Vecuronium Bromide | 1987 |
Recurarisation after vecuronium?
Topics: Female; Humans; Kidney Diseases; Neostigmine; Vecuronium Bromide | 1988 |
Importance of the level of paralysis recovery for a rapid antagonism of vecuronium with neostigmine in children during halothane anesthesia.
Topics: Anesthesia, Inhalation; Child; Child, Preschool; Halothane; Humans; Neostigmine; Neuromuscular Junction; Time Factors; Vecuronium Bromide | 1988 |
Antagonism of blockade produced by atracurium or vecuronium with low doses of neostigmine.
Topics: Adult; Atracurium; Female; Humans; Male; Neostigmine; Time Factors; Vecuronium Bromide | 1988 |
Intubation conditions and reversibility of a new non-depolarizing neuromuscular blocking agent, Org-NC45.
Topics: Adult; Anesthesia; Blood Pressure; Heart Rate; Humans; Intubation, Intratracheal; Neostigmine; Neuromuscular Nondepolarizing Agents; Pancuronium; Pyridostigmine Bromide; Time Factors; Vecuronium Bromide | 1980 |
Clinical pharmacology of ORG NC45 (NorcuronTM): a new nondepolarizing muscle relaxant.
Topics: Adult; Aged; Anesthesia, Inhalation; Halothane; Humans; Middle Aged; Muscle Contraction; Neostigmine; Neuromuscular Blocking Agents; Nitrous Oxide; Pancuronium; Time Factors; Vecuronium Bromide | 1981 |
Some actions of Org NC 45 and of edrophonium in the anaesthetized cat and in man.
Topics: Adult; Aged; Anesthesia, General; Animals; Cats; Edrophonium; Female; Humans; Male; Middle Aged; Muscle Contraction; Neostigmine; Neuromuscular Blocking Agents; Pancuronium; Time Factors; Vecuronium Bromide | 1982 |
The influence of halothane and enflurane on the reversibility of an Org NC45 neuromuscular blockade in cats.
Topics: Animals; Cats; Drug Interactions; Enflurane; Female; Halothane; Male; Neostigmine; Neuromuscular Blocking Agents; Pancuronium; Vecuronium Bromide | 1982 |
Clinical experience with ORG NC45 (norcuron) as the sole muscle relaxant.
Topics: Adult; Anesthesia, General; Female; Humans; Male; Middle Aged; Neostigmine; Neuromuscular Blocking Agents; Neuromuscular Junction; Pancuronium; Succinylcholine; Time Factors; Vecuronium Bromide | 1982 |
Clinical evaluation of Org NC 45.
Topics: Adult; Drug Evaluation; Humans; Intubation, Intratracheal; Muscle Contraction; Neostigmine; Neuromuscular Nondepolarizing Agents; Pancuronium; Time Factors; Vecuronium Bromide | 1983 |
Comparison of vecuronium, atracurium and tubocurarine in normal patients and in patients with no renal function.
Topics: Adolescent; Adult; Aged; Anesthesia, General; Atracurium; Blood Pressure; Female; Heart Rate; Humans; Intubation, Intratracheal; Isoquinolines; Kidney Failure, Chronic; Male; Middle Aged; Muscle Contraction; Neostigmine; Neuromuscular Blocking Agents; Pancuronium; Time Factors; Tubocurarine; Vecuronium Bromide | 1984 |
The effect of neostigmine on twitch tension and muscle relaxant concentration during infusion of mivacurium or vecuronium.
Topics: Adolescent; Adult; Humans; Isoquinolines; Middle Aged; Mivacurium; Muscle Contraction; Neostigmine; Neuromuscular Nondepolarizing Agents; Stereoisomerism; Vecuronium Bromide | 1995 |
Reversal of residual neuromuscular block with neostigmine at one to four hours after a single intubating dose of vecuronium.
Topics: Adult; Anesthesia; Female; Humans; Male; Middle Aged; Muscle Contraction; Neostigmine; Neuromuscular Junction; Time Factors; Vecuronium Bromide | 1995 |
Inadequate antagonism of vecuronium-induced neuromuscular block by neostigmine during sevoflurane or isoflurane anesthesia.
Topics: Adult; Anesthesia; Anesthetics; Dose-Response Relationship, Drug; Ethers; Female; Humans; Isoflurane; Male; Methyl Ethers; Middle Aged; Muscle Contraction; Neostigmine; Sevoflurane; Vecuronium Bromide | 1995 |
Resistance to vecuronium.
Topics: Adult; Carbamazepine; Drug Resistance; Electroencephalography; Epilepsy; Female; Humans; Neostigmine; Vecuronium Bromide | 1993 |
Neuromuscular effects of vecuronium and neostigmine in Montreal and Paris.
Topics: Adolescent; Adult; Aged; Anesthesia Recovery Period; Anesthesia, Inhalation; Anesthesia, Intravenous; Atropine; Female; Fentanyl; Humans; Intubation, Intratracheal; Male; Middle Aged; Muscle Contraction; Neostigmine; Neuromuscular Junction; Paris; Quebec; Thiopental; Time Factors; Ulnar Nerve; Vecuronium Bromide | 1994 |
Atropine facilitates neostigmine reversal of vecuronium-induced neuromuscular blockade.
Topics: Atropine; Dose-Response Relationship, Drug; Drug Synergism; Humans; Neostigmine; Vecuronium Bromide | 1993 |
Respiratory mechanics in anaesthetised patients after neostigmine-atropine. A comparison between patients with and without chronic obstructive pulmonary disease.
Topics: Airway Resistance; Atropine; Female; Forced Expiratory Volume; Functional Residual Capacity; Humans; Inhalation; Lung Compliance; Lung Diseases, Obstructive; Male; Middle Aged; Neostigmine; Pressure; Respiratory Mechanics; Tidal Volume; Vecuronium Bromide; Vital Capacity | 1993 |
The effect of reversal of myoneural blockade on cerebrospinal fluid pressure following cerebral aneurysm surgery.
Topics: Adult; Aged; Atrial Function, Right; Blood Pressure; Carbon Dioxide; Cerebrospinal Fluid Pressure; Cholinesterase Inhibitors; Elective Surgical Procedures; Female; Humans; Male; Middle Aged; Neostigmine; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Partial Pressure; Pressure; Pulmonary Ventilation; Vecuronium Bromide | 1995 |
Simple and cost effective clinical methods for measuring neuromuscular fade responses with emphasis on "train of four" fade.
Topics: Anesthesia, General; Cost-Benefit Analysis; Evaluation Studies as Topic; Hand; Humans; Intraoperative Period; Monitoring, Physiologic; Muscle Relaxation; Neostigmine; Neuromuscular Blockade; Neuromuscular Nondepolarizing Agents; Postoperative Period; Transducers, Pressure; Vecuronium Bromide | 1997 |
[Effects of halothane and sevoflurane on reversal of neuromuscular blockade induced by vecuronium in man].
Topics: Adult; Aged; Anesthesia, Inhalation; Anesthetics, Inhalation; Drug Residues; Ethers; Female; Halothane; Humans; Male; Methyl Ethers; Middle Aged; Monitoring, Physiologic; Neostigmine; Neuromuscular Blockade; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Sevoflurane; Vecuronium Bromide | 1997 |
Neuromuscular blocking and cardiovascular effects of Org 9487, a new short-acting aminosteroidal blocking agent, in anaesthetized animals and in isolated muscle preparations.
Topics: Adrenergic alpha-Agonists; Animals; Cats; Chickens; Cholinesterase Inhibitors; Dogs; Dose-Response Relationship, Drug; Ganglionic Blockers; Guinea Pigs; Heart; Hemodynamics; Macaca mulatta; Male; Muscle, Skeletal; Neostigmine; Neuromuscular Blockade; Neuromuscular Depolarizing Agents; Neuromuscular Nondepolarizing Agents; Norepinephrine; Pyridostigmine Bromide; Rats; Rats, Wistar; Succinylcholine; Time Factors; Vagus Nerve; Vecuronium Bromide | 1998 |
Undernutrition in children--effect on vecuronium induced neuromuscular blockade.
Topics: Body Mass Index; Child; Child, Preschool; Cholinesterase Inhibitors; Electric Stimulation; Evoked Potentials; Female; Humans; Infant; Male; Neostigmine; Neuromuscular Blockade; Neuromuscular Nondepolarizing Agents; Nutrition Disorders; Nutritional Status; Ulnar Nerve; Vecuronium Bromide | 1999 |
Is vecuronium toxicity abolished by hemodialysis? A case report.
Topics: Cholinesterase Inhibitors; Female; Graft Rejection; Humans; Kidney Transplantation; Middle Aged; Muscle Weakness; Neostigmine; Neuromuscular Nondepolarizing Agents; Renal Dialysis; Respiration, Artificial; Respiratory Paralysis; Vecuronium Bromide | 2000 |
Rapacuronium: first experience in clinical practice.
Topics: Ambulatory Surgical Procedures; Cholinesterase Inhibitors; Humans; Intubation, Intratracheal; Neostigmine; Neuromuscular Blockade; Neuromuscular Nondepolarizing Agents; Time Factors; Vecuronium Bromide | 2001 |
The influence of mild hypothermia on the pharmacokinetics and time course of action of neostigmine in anesthetized volunteers.
Topics: Adult; Anesthesia; Female; Humans; Hypothermia, Induced; Male; Neostigmine; Neuromuscular Nondepolarizing Agents; Parasympathomimetics; Vecuronium Bromide | 2002 |
Reversal of vecuronium with neostigmine in patients with diabetes mellitus.
Topics: Aged; Cholinesterase Inhibitors; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Neostigmine; Neuromuscular Blockade; Neuromuscular Nondepolarizing Agents; Respiration; Vecuronium Bromide | 2004 |
Neostigmine-induced prolonged neuromuscular blockade in a patient with atypical pseudocholinesterase.
Topics: Butyrylcholinesterase; Cholinesterase Inhibitors; Cystoscopy; Humans; Male; Middle Aged; Neostigmine; Neuromuscular Blockade; Neuromuscular Blocking Agents; Neuromuscular Diseases; Polycystic Kidney Diseases; Succinylcholine; Time Factors; Vecuronium Bromide | 2005 |
Muscle weakness after muscle relaxants: an audit of clinical practice.
Topics: Age Factors; Androstanols; Anesthesia, General; Cholinesterase Inhibitors; Female; Hand Strength; Humans; Male; Medical Audit; Muscle Weakness; Neostigmine; Neuromuscular Nondepolarizing Agents; Postoperative Period; Risk; Rocuronium; Sex Factors; Time Factors; Vecuronium Bromide | 2004 |
Coronary vasospasm during the reversal of neuromuscular block using neostigmine.
Topics: Cholinesterase Inhibitors; Coronary Vasospasm; Electrocardiography; Humans; Male; Middle Aged; Neostigmine; Neuromuscular Blockade; Neuromuscular Nondepolarizing Agents; Tongue Neoplasms; Vecuronium Bromide | 2005 |
Neostigmine-induced reversal of vecuronium in normal weight, overweight and obese female patients.
Topics: Adult; Body Mass Index; Body Weight; Cholinesterase Inhibitors; Female; Humans; Middle Aged; Neostigmine; Neuromuscular Blockade; Neuromuscular Nondepolarizing Agents; Obesity; Overweight; Vecuronium Bromide | 2006 |
Unwarranted administration of acetylcholinesterase inhibitors can impair genioglossus and diaphragm muscle function.
Topics: Acetylcholinesterase; Animals; Atropine; Cholinesterase Inhibitors; Data Interpretation, Statistical; Diaphragm; Dose-Response Relationship, Drug; Electromyography; Glycopyrrolate; Magnetic Resonance Imaging; Male; Muscarinic Antagonists; Neostigmine; Neuromuscular Nondepolarizing Agents; Pilot Projects; Rats; Rats, Sprague-Dawley; Respiratory Mechanics; Respiratory Muscles; Respiratory System; Vecuronium Bromide | 2007 |
[Investigations into neostigmine-induced inhibition of neuromuscular transmission].
Topics: Animals; Cats; Cholinesterase Inhibitors; Depression, Chemical; Dose-Response Relationship, Drug; Electric Stimulation; Evoked Potentials; Neostigmine; Neuromuscular Junction; Refractory Period, Electrophysiological; Vecuronium Bromide | 2009 |
Relative contribution of pre- and post-synaptic effects to the neostigmine-induced recovery of neuromuscular transmission blocked by vecuronium.
Topics: Animals; Cholinesterase Inhibitors; Electric Stimulation; Electrophysiological Phenomena; Female; Male; Muscle Contraction; Myography; Neostigmine; Neuromuscular Blockade; Neuromuscular Nondepolarizing Agents; Rats; Rats, Wistar; Sciatic Nerve; Synaptic Transmission; Vecuronium Bromide | 2011 |
Reversal of vecuronium with neostigmine: a comparison between male and female patients.
Topics: Adult; Aged; Cholinesterase Inhibitors; Female; Humans; Male; Middle Aged; Neostigmine; Neuromuscular Blockade; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Sex Characteristics; Vecuronium Bromide | 2009 |
Comparative Effectiveness of Calabadion and Sugammadex to Reverse Non-depolarizing Neuromuscular-blocking Agents.
Topics: Androstanols; Animals; Atracurium; Dose-Response Relationship, Drug; gamma-Cyclodextrins; Heterocyclic Compounds, 4 or More Rings; Male; Neostigmine; Neuromuscular Nondepolarizing Agents; Rats; Rocuronium; Sugammadex; Sulfonic Acids; Vecuronium Bromide | 2015 |
Sugammadex efficacy for reversal of rocuronium- and vecuronium-induced neuromuscular blockade: A pooled analysis of 26 studies.
Topics: Adult; Aged; Androstanols; Anesthesia Recovery Period; Anesthesia, General; Dose-Response Relationship, Drug; Female; gamma-Cyclodextrins; Humans; Male; Middle Aged; Neostigmine; Neuromuscular Blockade; Neuromuscular Nondepolarizing Agents; Placebos; Randomized Controlled Trials as Topic; Rocuronium; Sugammadex; Time Factors; Treatment Outcome; Vecuronium Bromide | 2017 |
Investigation of intraoperative dosing patterns of neuromuscular blocking agents.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Androstanols; Anesthesia, General; Atracurium; Body Mass Index; Electronic Health Records; Female; Humans; Male; Middle Aged; Monitoring, Intraoperative; Muscle Relaxation; Neostigmine; Neuromuscular Blockade; Neuromuscular Blocking Agents; Neuromuscular Nondepolarizing Agents; Prevalence; Retrospective Studies; Rocuronium; Sugammadex; Vecuronium Bromide; Young Adult | 2019 |
Effectiveness of sugammadex versus neostigmine on restoration of neuromuscular function in surgical patients with myasthenia gravis undergoing rocuronium-induced neuromuscular blockade: a systematic review protocol.
Topics: Anesthesia, General; Cholinesterase Inhibitors; Delayed Emergence from Anesthesia; Humans; Incidence; Myasthenia Gravis; Neostigmine; Neuromuscular Blockade; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Rocuronium; Sugammadex; Systematic Reviews as Topic; Time Factors; Vecuronium Bromide | 2018 |
Required dose of sugammadex or neostigmine for reversal of vecuronium-induced shallow residual neuromuscular block at a train-of-four ratio of 0.3.
Topics: Delayed Emergence from Anesthesia; Dose-Response Relationship, Drug; Humans; Neostigmine; Sugammadex; Vecuronium Bromide | 2022 |
Neuromuscular Blockade and Reversal Practice Variability in the Outpatient Setting: Insights From US Utilization Patterns.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Ambulatory Surgical Procedures; Anesthesia Recovery Period; Comorbidity; Databases, Factual; Ethnicity; Female; Humans; Male; Middle Aged; Neostigmine; Neuromuscular Blockade; Neuromuscular Depolarizing Agents; Neuromuscular Nondepolarizing Agents; Retrospective Studies; Rocuronium; Succinylcholine; Sugammadex; United States; Vecuronium Bromide; Young Adult | 2021 |
Optimizing Reversal of Neuromuscular Block in Older Adults: Sugammadex or Neostigmine.
Topics: Acetylcholine; Acetylcholinesterase; Aged; Cholinesterase Inhibitors; gamma-Cyclodextrins; Humans; Neostigmine; Neuromuscular Blockade; Neuromuscular Nondepolarizing Agents; Postoperative Complications; Rocuronium; Sugammadex; Vecuronium Bromide | 2022 |
The Nonirritating Concentrations of Neuromuscular Blocking Agents and Related Compounds.
Topics: Adult; Androstanols; gamma-Cyclodextrins; Humans; Neostigmine; Neuromuscular Blockade; Neuromuscular Blocking Agents; Neuromuscular Nondepolarizing Agents; Prospective Studies; Rocuronium; Succinylcholine; Sugammadex; Vecuronium Bromide | 2023 |